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The New World arenaviruses Junin, Machupo, and Guanarito are the causative agents of hemorrhagic fevers (HF) with high mortality in
humans. The cellular receptor for Old World arenaviruses and one subgroup of the New World arenaviruses (Clade C) have been identified as
α-dystroglycan (α-DG). In contrast, the receptor(s) of the South American HF viruses, which belong to the Clade B New World arenaviruses, are
currently unknown. To begin to characterize the cellular receptors used by these pathogens, we generated recombinant retroviral pseudotypes with
the glycoproteins of Guanarito, Junin, and Machupo. Infection with the South American HF viruses is independent of α-DG and functional
receptors for Guanarito, Junin, and Machupo were found on most human cell types and cells derived from non-human primate and rodents.
Guanarito, Junin, and Machupo share a common receptor, which is distinct from the receptor(s) used by the closely related non-pathogenic Clade B
virus Amapari, and the genetically more distant Clade A and C New World arenaviruses. We show that the cellular receptor(s) for the South
American HF viruses are proteins or protein-linked entities and that infection is not dependent on protein-linked N-glycans, O-glycans, or
glycosaminoglycans.
© 2006 Elsevier Inc. All rights reserved.Keywords: South American hemorrhagic fever viruses; ReceptorIntroduction
Several severe hemorrhagic fevers (HF), including Lassa
fever, Argentinian, Bolivian, and Venezuelan HF are caused by
arenaviruses (Buchmeier et al., 2001; Peters, 2002; Charrel and
de Lamballerie, 2003; Geisbert and Jahrling, 2004). Lassa fever
virus (LFV) is the causative agent of Lassa fever in Africa and
Junin virus causes Argentine HF, which is a significant public
health problem in Argentina. Machupo virus is the causative
agent of Bolivian HF, and Guanarito and Sabia virus have
emerged as etiological agents of severe HF in Venezuela and
Brazil, respectively.
Arenaviruses are enveloped single-strand RNA viruses with
a bisegmented genome in ambisense organization (Buchmeier
et al., 2001). Their genome consists of a large RNA segment
encoding the virus polymerase (L) and a small zinc finger motif⁎ Corresponding author. Fax: +1 858 784 99 81.
E-mail address: stefanku@scripps.edu (S. Kunz).
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doi:10.1016/j.virol.2006.02.033protein (Z), and a smaller RNA segment encoding the virus
nucleoprotein (NP) and glycoprotein (GP) precursor (GPC).
GPC is processed into the peripheral glycoprotein GP1 and the
transmembrane glycoprotein GP2. GP1 is implicated in receptor
binding (Parekh and Buchmeier, 1986; Borrow and Oldstone,
1992). GP2 is structurally similar to the fusion active membrane
proximal portions of the GPs of other enveloped viruses
(Gallaher et al., 2001; York et al., 2005). Upon receptor binding,
arenaviruses are internalized by uncoated vesicles and released
into the cytoplasm by a pH-dependent membrane fusion step
(Borrow and Oldstone, 1994; Castilla et al., 1994).
Arenaviruses are classified into two major groups: the Old
World arenaviruses with lymphocytic choriomeningitis virus
(LCMV) and Lassa fever virus (LFV) as representatives and the
larger group of the New World arenaviruses.
The New World arenaviruses are divided into three Clades,
A, B, and C (Bowen et al., 1996, 1997; Clegg, 2002). Clade A
includes the North American viruses Whitewater Arroyo, Bear
Canyon, and Tamiami, and the South American viruses
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contains the viruses Junin, Machupo, Guanarito, Sabia,
Tacaribe, Amapari, and Cupixi. Clade C contains the viruses
Oliveros, Latino, and Pampa.
The natural reservoir of a given arenavirus is represented by
one or a limited number of closely related rodent species, with
the notable exception of Tacaribe virus whose natural hosts are
bats. The present phylogenetic diversity of arenaviruses is most
likely the result of long-term co-evolution between viruses and
their corresponding host species, involving vertical and
horizontal transfer of viruses within and between populations,
respectively, and genetic recombination (Charrel et al., 2001,
2002, 2003; Archer and Rico-Hesse, 2002). All human
pathogenic New World arenaviruses are included in Clade B.
However, they do not form a common phylogenetic group, but
are distributed in sublineages, together with non-pathogenic
viruses. The pathogenic Junin and Machupo are associated with
Tacaribe virus that has so far caused only mild febrile illness in
infected laboratory workers and the pathogenic Guanarito virus
is found together with the non-pathogenic Amapari and Cupixi.
Considering the pivotal role of the virus-receptor interaction for
infection, tissue tropism, and pathogenesis, it is possible that
this remarkable variation in the disease potential among such
closely related viruses is linked, at least in part, to the use of
different host cell receptors.
While α-dystroglycan (α-DG) has been identified as the first
cellular receptor for the Old World arenaviruses and Clade C
New World arenaviruses (Cao et al., 1998; Spiropoulou et al.,
2002), the receptors used by Clade A and B New World
arenaviruses are currently unknown.
Our present study aimed at an initial characterization of the
cellular receptor molecules of the South American HF viruses.
By generating recombinant retroviral pseudotypes with the
glycoproteins of Guanarito, Junin, and Machupo, we found that
the cellular receptors used by these pathogens function
independently of α-DG and are found on most human cell
types and cells derived from non-human primates and rodents.
The HF viruses, Guanarito, Junin, and Machupo, share a
common receptor, which is distinct from the receptor(s) used
by the closely related non-pathogenic Clade B virus
Amapari, and the genetically more distant Clade A and C
New World arenaviruses. Biochemical characterization
revealed that the cellular receptor(s) for the South American
HF viruses are proteins or protein-linked entities, and that
infection is not dependent on the presence of protein-linked
N-glycans, O-glycans, or glycosaminoglycans.
Results
Retroviral vectors pseudotyped with the glycoproteins of
arenaviruses adopt the receptor binding characteristics of the
corresponding viruses
The South American HF viruses are BSL4 pathogens, which
restricts their use. To overcome this difficulty and perform
studies on the interaction of these viruses with their cellular
receptors under BSL2 conditions, retroviral vectors weregenerated that contain the glycoproteins (GPs) of these BSL4
viruses in their envelope. Enveloped viruses can incorporate
heterologous viral GPs into their lipid membranes during
budding (Suomalainen and Garoff, 1994) and these pseudo-
typed viruses acquire the receptor specificity of the virus from
which the heterologous GP is derived (Burns et al., 1993; Sutton
and Littman, 1996; Wool-Lewis and Bates, 1998). Using the
strategy outlined in Fig. 1A, we inserted the GPs of the South
American HF viruses Guanarito, Junin, and Machupo, and the
non-pathogenic Amapari into recombinant Moloney leukemia
virus (MLV). The retroviral genome pLZRs-Luc-gfp (Yang et
al., 1998) contains a bicistronic expression cassette with a
luciferase gene, followed by green fluorescent protein (GFP).
The full-length cDNAs of the GPs of Amapari, Guanarito,
Junin, and Machupo were obtained by PCR cloning using total
RNA isolated from infected cells (Materials and methods). In
addition, we generated pseudotypes containing the GPs of Lassa
fever virus (LFV), and of vesicular stromatitis virus (VSV).
Representative pseudotype titers are given in Table 1. Notably,
titers for Amapari, Guanarito, Junin, and Machupo pseudotypes
were routinely 5–10-fold lower than the titers obtained for LFV
or VSV pseudotypes. As anticipated, within the same cell type,
we found a direct correlation between the titers of infectious
pseudotypes as determined by detection of the GFP reporter and
luciferase activity (Fig. 1B).
Retroviral pseudotypes containing arenavirus GPs were
specifically recognized by the monoclonal antibody (mAb)
83.6, which binds to a highly conserved epitope in arenavirus
GPs (Weber and Buchmeier, 1988) (Fig. 1C). However, while
mAb 83.6 detected pseudovirions containing the GPs of
Amapari, Junin, and Machupo with similar sensitivity, reduced
signals were obtained with equal amounts of infectious
pseudotypes containing the GP of Guanarito. Since infectious
pseudotype titers for Guanarito tended to be similar to the ones
obtained with the other New World viruses, this discrepancy
may be caused by reduced binding affinity of mAb 83.6 for
Guanarito GP, due to differences in the amino acid sequence of
the conserved antigenic site (Fig. 1D).
Infection of cells by pseudotypes containing the GPs of
Amapari, Guanarito, and Junin was specifically blocked by the
corresponding inactivated viruses, but not by inactivated LFV
(Fig. 1E). As expected, none of the arenaviruses blocked
infection with VSV pseudotypes.
In line with our previous studies (Spiropoulou et al., 2002),
the Clade C New World arenaviruses Oliveros and Latino, but
neither the Clade B viruses Amapari, Guanarito, and Junin, nor
the Clade A viruses Parana and Pichinde showed significant
binding to α-dystroglycan (α-DG) (Fig. 2A). Next, we used
DG-deficient (DG−/−) mouse embryonic stem cells and their
hemizygous (DG+/−) parental line to test the dependence of
infection of the retroviral pseudotypes on α-DG. Consistent
with the binding studies shown in Fig. 2A, infection mediated
by the GPs of Amapari, Guanarito, Junin, and Machupo was
independent of α-DG (Fig. 2B). A high dependence on α-DG
was found for the infection with LFV pseudotypes, in line with
previous studies (Kunz et al., 2005). As expected, the VSV
pseudotypes infected DG-deficient cells with high efficiency.
Fig. 1. Recombinant retroviral vectors pseudotyped with arenavirus GPs. (A) Production of pseudotyped retroviruses: the packaging cell line GP2–293® stably
transfected with MLV gag and pol, is co-transfected with a plasmid containing the packable MLV genome pLZRS-Luc-gfp, which contains a luciferase and a GFP
reporter, and an expression plasmid for the heterologous GP (pC-NWAVGP). Retroviral pseudotypes are released into the cell supernatant. Infection of target cells
results in the integration of the retroviral genome into the host cell DNA and can be quantitated by detection of the luciferase or GFP reporter. (B) Infection of cells with
retroviral pseudotypes: supernatants containing pseudotypes were used to infect monolayers of HeLa cells in 96 well-plates. After 48 h, infection was quantified using
the Steady-Glo® luciferase reporter gene assay (Promega) in a Berthold 96 well-plate luminometer. Luminescence is expressed as fold-increase over uninfected
controls (n = 3 ± SD). (C) Binding of mAb 83.6 to pseudotypes: equal amounts of concentrated pseudotypes containing the GPs of Amapari (AMA), Guanarito (GUA),
Junin (JUN), Machupo (MAC), LFV, and VSV were immobilized in microtiter plates and probed with mAb 83.6 anti-LCMVGP2. Primary antibodies were detected
with HRP-conjugated anti-mouse IgG in a color reaction using ABTS substrate. OD (405) was measured using an ELISA reader (n = 3 ± SD). (D) Sequences at the
conserved antigenic site of mAb 83.6. The conserved antigenic site for mAb 83.6 (Weber and Buchmeier, 1988) is shown in bold face. The corresponding sequences of
LFV, Amapari, Guanarito, Junin, and Machupo are aligned. (E) Blocking of arenavirus pseudotype infection by inactivated viruses: HEK293 cells cultured in 96-well
plates blocked with inactivated viruses indicated ratios of inactivated infectious virus particles (PFU) per cell. After blocking for 2 h on ice, cells were infected with the
indicated pseudotypes at a multiplicity of infection (MOI) = 1. Infection was assessed by luciferase assay as in (B) (n = 3, ±SD).
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pseudotypes adopt the receptor binding specificities of the
viruses from which their GPs were derived.
Broad expression of functional receptors for the South
American HF viruses
The phylogenetic diversity of arenaviruses is likely the
result of long-term co-evolution between viruses and their
corresponding specific rodent host species. However, the
efficient and effective rodent-to-human transmission of the
South American HF viruses indicates the presence of
functional receptor molecules on cells of both rodents and
humans. To address this issue, we infected prototypic cell
lines derived from human (HEK293, HeLa), non-human
primate (Vero, CV-1), hamster (BHK, CHOK1), and mouse
(MC57, Balb/c) with retroviral pseudotypes containing the
GPs of Amapari, Guanarito, Junin, Machupo, and VSV.Pseudotype titers were determined by infection of HeLa cells
and identical multiplicities of infection (MOI) were used to
infect different cell lines. Infection was assessed by luciferase
assay. Pseudotypes of Guanarito, Junin, and Machupo
showed a similar pattern of infection, displaying high levels
in human and primate cells but lower levels in rodent cell
lines (Fig. 3A). Despite its close phylogenetic relationship
with the pathogenic Guanarito virus, the infection pattern of
pseudotypes of the non-pathogenic Amapari virus was
different, with low infectivity in cells of non-human primates
but high infection levels in rodent cells (Fig. 3A). As
anticipated, VSV pseudotypes infected all cell lines with high
efficiency, results consistent with the broad expression of the
VSV receptor (Rose and Whitt, 2001).
In humans, the South American HF viruses show broad
tissue tropism (Weissenbacher et al., 1987; Harrison et al., 1999;
Peters, 2002). However, examination of infected lymphatic
tissues of human cases found viral antigen predominantly in
Table 1
Representative titers of retroviral pseudotypes
Mean pseudotype titer in iu/ml (±SD)
AMAGP 0.8 (±0.3) × 105
GUAGP 1.2 (±0.4) × 105
JUNGP 1.0 (±0.5) × 105
MACGP 1.8 (±0.7) × 105
LFVGP 1.5 (±0.6) × 106
VSVGP 4.2 (±1.5) × 106
No GP <10
Recombinant retroviruses were pseudotyped with the GPs of the following
viruses: Amapari (AMAGP), Guanarito (GUAGP), Junin (JUNGP), Machupo
(MACGP), LFVGP, or VSVGP using the strategy described in Fig. 1A. In the
negative controls (no GP), empty pcAGGS vector was transfected. For the
determination of titers, serial dilutions of the pseudotypes were added to
monolayers of HeLa cells and GFP positive cells detected by immunofluores-
cence staining. Clusters of GFP positive cells counted and titers calculated as
infectious units (iu).
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lymphocytes. Using the pseudotypes, we asked if these distinct
susceptibilities to infection are due to differences in receptor
expression. To test for this possibility, we infected the human
cell lines HeLa (cervix epithelial), A549 (lung epithelial), Huh7
(hepatoma), and human umbilical vein endothelial cell
(HUVEC; microvascular endothelium) with pseudotypes of
Amapari, Guanarito, Junin, Machupo, and VSV (MOI = 1) and
the lines THP-1 (monocyte), WIL-2 (B cells), and Jurkat
(human T cells) with pseudotypes at MOI of 10. Results
indicated high levels of infection in HeLa, A549, Huh7,
HUVEC, and THP-1 cells, but lower levels in B and Tcells with
the pseudotypes of the highly pathogenic South American HF
viruses Guanarito, Junin, and Machupo (Fig. 3B). In contrast,
pseudotypes of the non-pathogenic Amapari infected Huh7 and
THP-1 cells with significantly lower efficiency.Fig. 2. Infection mediated by the GPs of Amapari, Guanarito, Junin, and Machupo i
New World arenaviruses: equal amounts the Clade A viruses Parana (PAR) and Pich
(JUN), as well as the Clade C viruses Oliveros (OLI) and Latino (LAT) were immo
concentrations. Bound α-DG-Fc fusion protein was detected with an HRP-conjugate
n = 3). (B) Infection with the South American HF pseudotypes is independent of α
cultured in 96-well plates were infected with arenavirus pseudotypes, VSV-PS, or p
luciferase assay using the more sensitive Bright-Glo luciferase reporter gene assay (P
fold-increase over uninfected controls (n = 3, ±SD).The South American HF viruses use a common cellular
receptor distinct from the one used by Amapari and Clade A
and C New World arenaviruses
Infection of human cells with Amapari, Guanarito, and Junin
pseudotypes was specifically blocked with the corresponding
inactivated viruses in a dose-dependent manner (Fig. 1E).
Following similar protocols, we tested the ability of inactivated
viruses to block pseudotypes containing different GPs. In our
blocking experiments, monolayers of HEK293H cells were pre-
incubated with increasing amounts of inactivated viruses on ice,
to allow blocking of cellular receptor binding sites. Incubation
with the retroviral pseudotypes was carried out in the presence
of the same concentrations of inactivated competitor virus to
prevent dissociation of the inactivated competitor virus from its
binding sites. Blocking of HEK293 cells with inactivated
Amapari resulted in a significant reduction of subsequent
infection with Amapari pseudotypes but not with the group of
the South American HF virus pseudotypes (Fig. 4A). Pre-
incubation of cells with inactivated Guanarito and Junin virus
did not block infection with Amapari pseudotypes but
significantly reduced infection of the South American HF
pseudotypes (Fig. 4A). Blocking of cells with up to 5000 PFU
of inactivated Clade C (Oliveros, Latino) and Clade A viruses
(Parana, and Pichinde) did not significantly affect infection with
the Clade B pseudotypes (Figs. 4B, C). Furthermore, only
blocking with Parana and Pichinde, but not the other New
World arenaviruses, reduced infection with Pichinde (Fig. 4D).
In summary, these data indicate that the South American HF
viruses use a common cellular receptor and that this receptor is
distinct from the one used by Amapari and the Clade A viruses
Parana and Pichinde (Fig. 4E). The fact that 100–500 PFU of
inactivated virus per cell were required for significant blocking
of pseudotype infections suggests further that the receptors useds independent of α-DG. (A) Binding of recombinant α-DG-Fc fusion protein to
inde (PIC), the Clade B viruses Amapari (AMA), Guanarito (GUA), and Junin
bilized in microtiter plates and incubated with purified DGFc5 at the indicated
d anti-human Fc antibody in a color reaction using ABTS substrate (mean ± SD;
-DG: DG-deficient DG (−/−) and DG (±) mouse embryonic stem cells (ESC)
seudotypes containing no GP (MOI = 10). Infection was assessed after 48 h by
romega) in a Berthold 96 well-plate luminometer. Luminescence is expressed as
Fig. 3. Infection of different cell lines with pseudotypes: cells of the indicated lines derived from different mammalian species (A), and human cell types (B) wer ltivated in 96 well plates and infected with retroviral
pseudotypes containing the GPs of Amapari (AMA), Guanarito (GUA), Junin (JUN), Machupo (MAC) viruses and VSV. As a negative control, retroviruses la g GP (no GP) were used. Infection was assessed by
luciferase assay as in Fig. 1B (n = 3; ±SD). Cells in (A) are derived from human (HEK293, HeLa), non-human primate (Vero, CV-1), hamster (BHK, CHOK1), mouse (MC57, Balb/c). Cells in panel B are derived
from the following human cell types: cervix epithelial (HeLa), lung epithelial (A549), hepatoma (Huh7), microvascular endothelium (HUVEC), monocyte crophage (THP-1), B lymphocytes (WIL-2), and T
lymphocytes (Jurkat). For all cell lines except THP-1, WIL-2, and Jurkat, pseudotypes were used at an MOI of 1 (determined by infection of HeLa cells). For in ion of THP-1, WIL-2, and Jurkat, an MOI of 10 was
used.
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Fig. 4. The South American HF viruses use a common cellular receptor distinct from the one used by Amapari and Clade A and C viruses. HEK293 cells cultured in 96-well plates were blocked with the inactivated Clade
B viruses Amapari (AMA), Guanarito (GUA), and Machupo (MAC) (A); the Clade C viruses Oliveros (OLI) and Latino (LAT) (B); or Clade A viruses Parana (PAR) and Pichinde (PIC) (C) at the indicated ratios of
inactivated infectious virus particles (PFU) per cell. After blocking for 2 h on ice, cells were infected with the indicated pseudotypes at a multiplicity of infection (MOI) = 1. Infection was assessed by luciferase assay as in
Fig. 1B (n = 3, ±SD). (D) Blocking of Pichinde infection: HEK293 cells cultured in Permanox 8-well LabTek tissue chamber slides were blocked with inactivated viruses at the indicated ratios of inactivated infectious
virus particles per cell and subsequently infected with 500 PFU of live Pichinde virus. After 36 h, cells were fixed and stained for GP using a mixture of the broadly specific anti-GP mAbs 83.6 and 33.1 and a FITC-
conjugated secondary antibody. Clusters of GP positive cells were scored as one infection event. Results are infection events per well (n =3; ±SD). (E) Summary of blocking results with significant blocking (+) and no
detectable blocking with up to 5000 PFU of inactivated virus per cell (−) indicated.
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molecules.
The cellular receptor(s) for the South American HF viruses are
proteins or protein-bound entities
To analyze the biochemical nature of the receptors for
Guanarito, Junin, and Machupo on human cells, we used
HEK293H cells, which can be cultivated either as an adherent
cell line in serum-containing medium or in suspension culture
using serum-free medium. To determine the biochemical nature
of the receptor(s) for Guanarito, Junin, and Machupo on
HEK293H cells, we first treated cells kept in single cell
suspension with a series of proteases, lipases, or glycosidases
and then assessed the effects of these various enzyme treatments
on subsequent pseudotype infection. Treatment with the
proteases trypsin and proteinase K resulted in reduction of
subsequent infection with Guanarito, Junin, and Machupo
pseudotypes (Fig. 5A). The specificity of the effect of the
protease treatment on infection by the South American HF virus
pseudotypes was confirmed by an insignificant effect on
infection with VSV pseudotypes, which use a non-protein
receptor (Rose andWhitt, 2001). In contrast to the data obtained
with proteases, treatment of cells with the phospholipases
PLA2, PLC, or PLD did not have a significant effect on
subsequent infection with the South American HF virusFig. 5. The cellular receptor(s) for Guanarito, Junin, and Machupo viruses are likely p
treated with the following enzymes (black bars) or the corresponding reaction buffe
phospholipases: phospholipase A2 (PLA2), phospholipase C (PLC), phospholipase D
treatment, cells were washed and incubated with the Guanarito (GUA), Junin (JUN), M
washed and incubated for 48 h at 37 °C. Infection was quantified by luciferase assa
proteins by PI-PLC. HEK293H cell and the Thy-1.2 positive lymphocyte cell line EL
infected with Guanarito (GUA), Junin (JUN), and Machupo (MAC) pseudotypes as
marker protein Thy1.2. Live, non-permeabilized cells were stained with an anti-Thy
and analyzed using a FACSCalibur® flow cytometer and FloJo® software. Data arepseudotypes (Fig. 5B). Treatment with up to 100 U/ml PI-
PLC from Bacillus cereus, which removes glycosyl-phospha-
tidyl-inositol (GPI) anchored moieties from the cell surface, did
not reduce infection, indicating that the receptors are not GPI-
linked (Figs. 5B, C). As a control, we determined the effect of
PI-PLC treatment on cell surface levels of the GPI-anchored
Thy-1 protein on EL-4 thymoma cells by flow cytometry
(Borrow and Oldstone, 1992) and found that treatment with
100 U/ml PI-PLC reduced the expression of Thy-1 on EL-4
cells to undetectable levels (Fig. 5C).
To address the role of protein-linked carbohydrates, we
treated single cell suspensions of HEK293H cells with a panel
of endo- and exoglycosidases (Fig. 6). To address the role of
N-linked carbohydrates, cells were treated with N-glycosidase
A (PNGaseA), which hydrolyzes all types of N-glycan chains
from glycopeptides. To specifically test for the involvement of
high mannose N-glycans, we used a combination of the
enzymes α(1–2,3) mannosidase and α(1–6) mannosidase that
remove terminal mannose residues present in high-mannose
and hybrid-type N-glycans.
In contrast to N-glycans, removal of protein-linked
O-glycans is complicated by their higher structural diversity.
Core 1 O-glycans present on a variety of cellular glycoproteins
can be removed by O-glycosidase, which hydrolyzes O-linked
Galβ(1-3)GalNAc-moieties. Since O-glycosidase is sensitive to
sialic acid linked to the Galβ(1–3)GalNAc core, we used theroteins or protein-bound entities. Single cell suspensions of HEK293H cells were
r control (white bars): proteases (A): proteinase K (PK) and trypsin (TR); (B)
(PLD), and phosphoinositol-specific phospholipase C (PIPLC). After enzyme
achupo (MAC), and VSV pseudotypes at an MOI of 1 for 2 h on ice. Cells were
y as in Fig. 1B (n = 3; ±SD). (C) Verification of the removal of GPI-anchored
-4 were incubated with the indicated amounts of PI-PLC. HEK293H cells were
in panel B. EL-4 cells were examined for the expression of the GPI-anchored
1.2 antibody, combined with a phycoerythrine (PE)-labeled secondary antibody
triplicates of Thy1.2 positive cells (±SD).
Fig. 6. Infection of cells with South American HF virus pseudotypes after treatment with endo- and exoglycosidases. Single cell suspensions of HEK293 cells were
treated with N-glycosidase A (N-Glyc), O-glycosidase (O-Glyc), a combination of neuraminidase and O-glycosidase (Neu/O-glyc), neuraminidase (Neu), a
combination of α(1–2, 3) and α(1–6) mannosidase (Man), β-N-acetyl-hexosaminidase (β-NAcHex), α-N-acetyl-galactosaminase (α-NAcGal), α(1–2) fucosidase
(Fuc), and β(1–3, 4, 6) galactosidase (Gal). After treatment with enzymes (black bars) and control reaction buffers (white bars), cells were washed and infected with
the Guanarito (GUA), Junin (JUN), and Machupo (MAC) pseudotypes as in Fig. 5A.
483J.M. Rojek et al. / Virology 349 (2006) 476–491enzyme either alone or in combination with neuraminidase from
Arthrobacter urefaciens that cleaves α(2–3, 6, 8)-linked sialic
acid (SiaA). While treatment of cells with O-glycosidase alone
had no effect on pseudotype infection, pre-treatment with both
enzymes caused a small but consistently observed increase of
subsequent infection (Fig. 6).
The possible involvement of specific terminal sugar
moieties was addressed by treatment of cells with the fol-
lowing exoglycosiases: α-N-acetyl-galactosaminase (cleaves
terminal α-linked N-acetyl-galactosamine), α(1–2) fucosidase
(cleaves α(1–2) linked fucose), neuraminidase from A.
urefaciens, β-N-acetyl-hexosaminidase (cleaves terminal β-
linked N-acetyl-glucosamine), and β(1–3, 4, 6) galactosidase
(cleaves terminal β-linked galactose). None of the treatments
resulted in a significant reduction of subsequent infection with
Guanarito, Junin, and Machupo pseudotypes (Fig. 6A).
To verify that the enzymes were used at concentrations
and conditions where they can efficiently remove the cor-
responding sugars from cell surface glycoproteins, we
monitored the enzymatic remodeling of oligosaccaride chains
of well-characterized glycoproteins. Since deglycosylation in
solution does not reflect the removal of sugars from mem-
brane-associated glycoproteins present at the cell surface, we
choose an assay format involving immobilized glycoproteins
(Orberger et al., 1993). Briefly, the purified reference
glycoproteins transferrin, fetuin, asialofetuin, and carboxy-
peptidase Y (CPY) were immobilized in polystyrene surfaces
of microtiter plates and incubated with the enzymes in the
same concentrations and buffer conditions used for treatment
of HEK293H cells. Removal of the corresponding sugars
was then verified by binding to a panel of specific lectins
(see Supplemenatry Table S1). As shown in the Supplmen-
tary Fig. S1, treatment of glycoproteins with N-glycanase,
O-glycanase, neuraminidase, β-galactosidase, and mannosi-
dase removed >90% of the corresponding protein-linked
sugars. β-N-acetyl-hexosaminidase and α-N-acetyl-galactosa-
minase were less efficient.Taken together, our data provide evidence that the cellular
receptor(s) for the South American HF viruses are proteins or
protein-bound entities. However, due to the limited range and
efficiency of our reagents, our data on the specific role of
protein-linked carbohydrate structures in infection with the
South American HF viruses remained at this point inconclusive.
Infection of the South American HF viruses is not dependent on
protein-linked N-glycans, core O-glycans, and
glycosaminoglycans
As a complementary approach to address the role of protein-
linked N- and O-glycans for infection of cells with the South
American HF viruses, we used the well-described glycosyla-
tion-deficient CHO-derived mutant cell line ldlD (Krieger,
1983). The ldlD cell line has a defect in the enzyme UDP-Gal/
UDP-GalNAc 4-epimerase that converts UDP-glucose (UDP-
Glc) and UDP-N-acetylglucosamine (UDP-GlcNAc) into UDP-
galactose (UDP-Gal) and UDP-N-acetylgalactosamine (UDP-
GalNAc). When grown in serum-free medium, ldlD cells
contain very low intracellular pools of UDP-Gal and UDP-
GalNAc, which are the donor substrates for the enzymes
involved in transfer of galactose or GalNAc to proteins
(Park and Tenner, 2003). The biosynthesis of all core protein
O-glycans is prevented since GalNAc is the first sugar to be
added to serine or threonine (Fig. 7A). Protein N-glycosylation
is altered as the cells lack galactose and are unable to
synthesize Gal β(1–4)-linked moieties of complex and hybrid
type N-glycans. In addition, absence of UDP-Gal and UDP-
GalNAc results in an inability of the cells to synthesize the
glycosaminoglycans chondroitin sulfate, dermatan sulfate, and
keratan sulfate. In contrast, the biosynthesis of heparan sulfate
(HS) is not affected. Supplementation of the culture medium
with galactose restores normal N-glycosylation, with the
exception of the rare GalNAc modification of N-glycans. In
contrast, O-glycosylation remains blocked (Fig. 7A). Addition
of GalNAc alone results in synthesis of truncated O-linked
Fig. 7. Infection of the South American HF viruses is not dependent on protein-linked complex N-glycans, core O-glycans, chondroitin-, dermatan-, or keratan sulfate.
(A) Glycosylation defects in ldlD cells under different culture conditions. The following code is used for sugars: white square, N-acetylgalactosamine; black square,
N-acetylglucosamine; white circle, mannose; black circle, galactose; triangle, fucose; diamond, sialic acid. Glycosaminoglycans (GAGs) are abbreviated as follows:
chondroitin sulfate (CS), dermatan sulfate (DS), keratan sulfate (KS), and heparan sulfate (HS). (B) Infection of ldlD cells with South American HF virus
pseudotypes: after 48 h of culture in serum free medium without supplements or supplemented with either 20 μM galactose (Gal), 400 μM GalNAc (GalNAc), or
both (Gal + GalNAc), ldlD cells were infected with Guanarito (GUA), Junin (JUN), Machupo (MAC), and VSV pseudotypes, at an MOI of 1. Infection was
quantified after 48 h by luciferase assay as in Fig. 1B (n = 3; ±SD).
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Supplementation of the medium with galactose and GalNAc
restores the normal pattern of protein glycosylation. After
culture under the corresponding conditions for at least 48 h,
ldlD cells were infected with Guanarito, Junin, Machupo, and
VSV pseudotypes and infection assessed by luciferase assay.
Remarkably, we observed an inverse correlation between
protein glycosylation and infection of ldlD cells with the
South American HF virus pseudotypes (Fig. 7B). While
supplementation with Gal or GalNAc alone resulted in only a
mild reduction in infection, a significant decrease (>80%) of
infection was observed after addition of Gal and GalNAc, which
restores normal protein N- and O-glycosylation.
Although ldlD cells cultured in the absence of Gal and
GalNAc are deficient in the glycosaminoglycans chondroitin-,
dermatan-, or keratan sulfate, they have normal levels of
heparan sulfate, a glycosaminoglycan implicated in host cell
attachment of many viruses (Olofsson and Bergstrom, 2005). To
address the role of heparan sulfate in the infection of cells with
the South American HF viruses, we used a two-pronged
approach. First, we made use of the mutant CHO cell line pgsA-
745 that is deficient in UDP-D-xylose: serine-1, 3-D-xylosyl-
transferase and lacks all glycosaminoglycans (Esko et al.,
1985). PsgA-754 and wild-type CHOK1 cells were infected
with pseudotypes of Guanarito, Junin, and Machupo, as well as
VSV-pseudotypes that do not depend on glycosaminoglycans
for infection. As shown in Fig. 8A, the South American HF
virus pseudotypes infected both cell types with similar
efficiency. In a complementary approach, we tried to block
infection with Guanarito, Junin, and Machupo pseudotypes
with soluble heparan sulfate and heparin. Consistent with ourfindings with the psgA-745 mutant cell line, no significant
blocking of infection was observed with up to 100 μg/ml
heparan sulfate or heparin.
Together, our data indicate that the cellular receptor(s) for the
South American HF viruses are proteins or protein-linked
entities and infection is not dependent on protein-linked N-
glycans, O-glycans, or glycosaminoglycans.
Discussion
Our study aimed at the initial characterization of the yet
unknown cellular receptor(s) used by the South American HF
viruses Guanarito, Junin, and Machupo and makes the
following points: First, infection with Guanarito, Junin, and
Machupo is independent of α-DG, a cell surface protein that
serves as a cellular receptor for Old World and Clade C New
World arenaviruses. Second, functional receptors for the South
American HF viruses were found on human, primate, and
rodent cells. Third, that the receptor shared by the human
pathogenic viruses Guanarito, Junin, and Machupo is distinct
from the receptor(s) used by the non-pathogenic Clade B virus
Amapari, and the receptor(s) for the Clade A New World
arenaviruses. Fourth, the cellular receptor(s) for the South
American HF viruses are proteins or protein-linked entities and
infection is not dependent on protein-linked N-glycans, O-
glycans, or glycosaminoglycans.
The only arenavirus receptor identified so far is α-
dystroglycan (α-DG), which serves a major receptor for the
OldWorld arenaviruses and Clade C NewWorld viruses (Cao et
al., 1998; Spiropoulou et al., 2002). α-DG is not used by the
prototypic Clade A and B viruses Parana and Amapari,
Fig. 8. Infection of the South American HF viruses is not dependent on glycosaminoglycans. (A) Infection of glycosaminoglycan-deficient and wild-type CHO cells
with pseudotypes: glycosaminoglycan-deficient CHO mutant psgA-745 cells and CHOK1 cells were infected with Guanarito (GUA), Junin (JUN), Machupo (MAC),
and VSV pseudotypes, at an MOI of 1. Infection was quantified after 48 h by luciferase assay as in Fig. 1B (n = 3; ±SD). (B) Blocking of pseudotype infection with
heparan sulfate and heparin: Guanarito (GUA), Junin (JUN), and Machupo (MAC) pseudotypes were pre-incubated with the indicated concentrations of heparan
sulfate and heparin for 1 h on ice and then added to monolayers of Vero cells (MOI of 1). Infection was quantified after 48 h by luciferase assay as in A (n = 3; ±SD).
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infection by Junin and Machupo virus (Reignier et al., 2004). In
line with these studies, we found high affinity α-DG binding
with the Clade C viruses Oliveros and Latino, but no detectable
binding with all Clade A and B viruses tested. Using infection
of DG-deficient mouse embryonic stem cells with retroviral
pseudotypes, we confirm that the infection mediated by the GPs
of Guanarito, Junin, and Machupo is independent of α-DG. The
lack of a role for α-DG for the infection with the South
American HF viruses, together with the dependence of the Old
World HF arenavirus LFV on α-DG (Cao et al., 1998; Kunz et
al., 2005), suggests that use of α-DG as a cellular receptor is not
a requirement for arenavirus HF pathology in humans. The
propensity of particular arenaviruses to cause HF in humans
may depend on the use of other cellular receptors and/or aspects
of virus–host cell interaction downstream of receptor binding
and entry.
Cells derived from human, non-human primates, hamster,
and mouse were highly susceptible to infection with retroviral
pseudotypes of Amapari, Guanarito, Junin, and Machupo,
indicating expression of functional receptors on cells derived
from rodents and primates. In accordance with the reported
tissue tropism of the South American HF viruses in humans
(Weissenbacher et al., 1987; Harrison et al., 1999; Peters, 2002),
we found efficient infection of Guanarito, Junin, and Machupo
pseudotypes of human fibroblasts, lung epithelial cells,
hepatoma cells, vascular endothelial cells, and monocytes but
lower levels in lymphocyte lines. The efficient infection of all
cell types with VSVGP pseudotypes indicates that the observed
differences in infection with the arenavirus pseudotypes are not
due to a block in retroviral integration or reporter gene
expression. Since both arenavirus GPs and VSVGP mediate
infection of host cells via receptor-mediated endocytosis,
followed by a pH-dependent membrane fusion step (Borrow
and Oldstone, 1994; Castilla et al., 1994; Rose and Whitt,
2001), it appears unlikely that reduced infection with thearenavirus pseudotypes is due to a block in endocytosis or GP-
mediated membrane fusion. The infection patterns observed
with our pseudovirions are most likely dependent on differential
expression of functional cellular receptors.
In all cell types studied, the pathogenic viruses Guanarito,
Junin, and Machupo displayed a similar infection pattern, which
was distinct from that observed with the non-pathogenic
Amapari virus. Among human cells, marked differences were
observed with the hepatocyte- and monocyte-derived cell lines
Huh7 and THP-1, respectively. While both cell lines were
efficiently targeted by pseudotypes of the pathogenic viruses,
significantly lower infection levels were found with Amapari.
Interestingly, infection of cells of the monocyte/macrophage
lineage and also the liver are thought to be crucial for the
pathogenesis of viral hemorrhagic fevers in humans (Geisbert
and Jahrling, 2004).
Another line of evidence for differential receptor use of
Guanarito, Junin, and Machupo on the one hand, and Amapari
on the other hand, comes from our receptor blocking assays
indicating that the pathogenic viruses share common receptor(s)
on human cells that are different from the receptor(s) used by
Amapari. In addition, there appears to be no overlap in receptor
use between Clade B viruses and viruses derived from Clades A
and C. These observed differences in receptor use may be the
result of evolutionary constraint on the viruses due to their long-
term relationships with specific rodent host species and their
consequent structural and genetic divergence. The closely
related Junin and Machupo viruses, which share a common
receptor, are both hosted by rodents of one genus, Calomys
musculinus and Calomys callosus, respectively (Salazar-Bravo
et al., 2002). Parana and Pichinde, which appear to use
overlapping receptor(s), are carried in nature by rodents of the
same genus Oryzomys (Bowen et al., 1997). However, while the
primary natural host for Guanarito is Zygodontomys brevicauda
(Weaver et al., 2000), Amapari is hosted by rodents of two
distinct genera, Neacomys guianea and Oryzomys capito. The
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arenaviruses may be linked to the higher genetic complexity of
the New World group, which evolved as a consequence of the
remarkable diversity of their corresponding host species.
To determine the biochemical nature of the cell surface
component(s) on human cells to which the GPs of the South
American HF viruses bind, the effect of selective removal of
different host cell membrane components on pseudotype
infection was investigated. Treatment of prototypic human
cells with proteases but not phospholipases significantly
reduced infection with Guanarito, Junin, and Machupo
pseudotypes, indicating that the cellular receptor(s) for these
viruses are either protein(s) or protein-bound entities. These
findings are in line with previous studies in which protease
treatment of Vero cells reduced binding to Junin virus (Raiger
Iustman et al., 1995, 1998).
Using enzymatic glycan removal from the cell surface, we
addressed the role of protein-linked glycans for infection with
Guanarito, Junin, and Machupo viruses. While treatment with
most endo- and exoglycosidases did not significantly affect
pseudotype infection, we noted a small but significant increase
of susceptibility after combined treatment with O-glycosidase
and neuraminidase. Since O-glycosidase cleaves only unsub-
stituted Galβ(1–3)GalNAc-moieties of core O-glycans, the
increases infection observed after combined treatment with
neuraminidase and O-glycosidase may be due to the removal of
sialylated core O-glycans. Considering the limitations of
enzymatic deglycosylation, we complemented this approach
with studies in well-described glycan-deficient cells. To address
a potential role of glycosaminoglycans in the infection of South
American HF viruses, we used the glycosaminoglycan-deficient
mutant CHO cell line psgA-745. When compared with wild-
type cells, psgA745 cells revealed no detectable difference in
susceptibility to Guanartio, Junin, and Machupo pseudotypes,
excluding a significant role for glycosaminoglycans in the
infection with South American HF viruses. In addition, we used
the CHO mutant cell line ldlD, which is deficient in the
biosynthesis of Gal and GalNAc and therefore lacks all
Galβ(1–3)GalNAc containing core O-glycans and the distal
SiaAα(2–6)Galβ(1–4)-moieties of N-glycans. Reconstitution
of normal N-glycosylation by addition of Gal and restoration the
GalNAc moieties of core O-glycans after supplementation of
GalNAc resulted in a slight reduction in susceptibility of ldlD
cells to infection with the South American HF virus pseu-
dotypes. However, a significant (>80%) reduction of infection
was observed after addition of Gal and GalNAc, which restore
the normal protein-glycosylation pattern. This inverse correla-
tion between protein glycosylation and susceptibility to
infection excludes an essential role of generic N- and O-linked
glycans for the infection of cells with Guanarito, Junin, and
Machupo. The data rather suggest that specific protein-linked
sugars somehow interfere with optimal virus-receptor binding.
The nature of the glycans involved is at present unclear. Since
supplementation of ldlD cells with a combination of Gal and
GalNAc is required for a significant reduction in susceptibility
to occur, one might speculate that substituted, e.g. sialylated,
Galβ(1–3)GalNAc core O-glycans are involved, as suggestedby the data obtained with enzymatic remodeling. Overall, our
results on the role of protein-linked glycans for infection of the
South American HF viruses differ from other viruses, like
influenza (Chu and Whittaker, 2004), Newcastle disease virus
(Ferreira et al., 2004), and HIV (Wang et al., 2004), for which
there is an important role for carbohydrate moieties in the
recognition of cellular receptor proteins.
Lastly, the development of retroviral pseudotypes for the
South American HF viruses, together with our biochemical
characterization of their cellular receptors, sets the stage for the
isolation and in-depth characterization of the receptor molecules
for these important human pathogens.
Materials and methods
Reagents, proteins, and antibodies
The fusion protein DGFc5 represents a transcriptional
fusion of α-DG with the Fc moiety of human IgG1 and was
expressed and purified from HEK293T cells as described
(Kanagawa et al., 2004). Purified transferrin, fetuin, asialofe-
tuin, and carbotypeptidase Y were purchased from Roche
(Mannheim, Germany). Biotinylated lectins GNA (Galanthus
nivalis agglutinin), SNA (Sambucus nigra agglutinin), MAA
(Maackia amurensis agglutinin), PNA (Peanut agglutinin),
ECA (Erythrina cristagalli agglutinin), VVA (Vicia villosa
Lectin), and GsII (Griffonia simplicifolia lectin II) were from
Vector laboratories (Burlingame, CA).
Monoclonal antibodies (mAb) 33.1 and 83.6 (anti-
LCMVGP2) have been described (Buchmeier et al., 1981;
Weber and Buchmeier, 1988). The rabbit anti-GFP polyclonal
Ab was from Chemicon. The rat mAb 30.H12 anti-mouse
Thy1.2 was from ATCC (Borrow and Oldstone, 1992). FITC-
conjugated anti-rabbit IgG and phycoerythrin (PE)-conjugated
anti-rat IgG were from Jackson Immuno-Research (West Grove,
PA), and the HRP-conjugated anti-mouse IgG was from Pierce
Chemical Co. (Rockford, IL). The SteadyGlo® andBright-Glo®
luciferase assay systems were obtained from Promega (Madison
WI). Heparan sulfate and heparin were purchased from Sigma.
Cell lines
African green monkey kidney (Vero-E6) cells were main-
tained in Dulbecco's modified Eagle medium (DMEM) (Gibco
BRL, Grand Island, NY) containing 10% fetal calf serum
(HyClone, Logan, UT). HEK293H cells were purchased from
GIBCO BRL. For culturing as adherent cells, HEK293H was
kept in complete serum-containing medium: DMEM, 10% (vol/
vol) FBS, supplemented with glutamine, and penicillin/
streptomycin. For suspension cultures, cells were briefly
trypsinized, washed twice in DMEM, and resuspended in the
chemically defined serum-free medium 293 SFMII (GIBCO).
The cell lines HeLa, CV-1, BHK, Balb/c murine fibroblasts,
A549 human lung carcinoma cells (ATCC CCL-185), the
human hepatoma cell line Huh7 (Nakabayashi et al., 1982,
1984), and the mouse lymphoma line EL-4 were cultured in
DMEM, 10% (vol/vol) FBS, supplemented with glutamine, and
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10% (vol/vol) FBS, supplemented with glutamine, and
penicillin/streptomycin and CHOK1 cells in HAMF12, 10%
(vol/vol) FBS, supplemented with 10 mM HEPES, pH 7.5,
glutamine, and penicillin/streptomycin. Human umbilical cord
vascular endothelial cells (HUVEC) were purchased from
Cambrex (Walkersville, MD) and cultured in endothelial cell
medium according to the company's recommendations.The
human monocyte cell line THP-1 (ATCC TIB 202) was kept in
RPMI, 10% (vol/vol) FBS, supplemented with glutamine, and
penicillin/streptomycin, 10 mM HEPES, pH 7.4, and 50 μM
β-mercaptoethanol. The human B cell line WIL-2 NS, the
human T cell line Jurkat was cultured in RPMI, 10% (vol/vol)
FBS, supplemented with glutamine, and penicillin/streptomy-
cin. DG (+/−) and DG (−/−) embryonic stem (ES) cells were
maintained as described (Henry and Campbell, 1998). The
mutant cell lines ldlD (Krieger, 1983) were kept in HAMF12,
10% (vol/vol) FBS, supplemented with glutamine, and penicil-
lin/streptomycin, 15 mM HEPES. Where indicated, cells were
maintained in the serum-free medium CHO-SFM II supplemen-
ted with glutamine, and penicillin/streptomycin. To reconstitute
wild-type glycosylation in ldlD cells, 20 μM galactose (Sigma)
and 400 μM GalNAc (Sigma) were added for at least 48 h prior
to experimentation as described (Park and Tenner, 2003).
The glycosaminoglycan-deficient CHO cell line psgA-745
was obtained from ATCC. PsgA-745 cells and control wild-type
CHO cells were kept in Ham's F12K medium supplemented
with 10% (vol/vol) FBS and 1.5 g/l sodium bicarbonate.
Virus strains, purification, and quantification
Seed stocks of Pichinde were prepared by growth in BHK-21
cells. Purified virus stocks were produced and titers determined
as described (Dutko and Oldstone, 1983). Lassa fever virus
(LFV) strain Josiah and the other New World arenaviruses used
in this study were obtained from the collection at the Special
Pathogens Branch, Center for Disease Control and Prevention in
Atlanta GA. The passage history for each virus is as follows:
Amapari SM13,V1, E6 + 1; Parana: SHB5,V1, E6 + 1;Oliveros:
E6 + 2; Latino: SHB6, V1, E6 + 1; Machupo (Carvallo): SM80,
E6 + 1; Junin (XJ-13): GP2, SMB13, E6 + 1; Guanarito (VINH-
9551): RD1, SM2, E6 + 1.
Amapari, Parana, Oliveros, Latino, Guanarito, Junin,
Machupo, and LFV were grown in Vero-E6 cells in a
BSL4 facility, polyethylene glycol-precipitated and γ-inacti-
vated as described (Elliott et al., 1982). Inactivation was
verified by a double blind passage of the inactivated viruses
on Vero E6 cells followed by immunofluoresence staining for
detection of viral antigen. Pichinde virus was inactivated by
UV irradiation as described (Kunz et al., 2004). Inactivation
was verified by plaque assay on Vero cells. The work with
most of the infectious viruses was done at biosafety level 3
(BSL-3), with the exception of LFV, Guanarito, Junin, and
Machupo viruses, which were handled in the BSL-4
laboratories at the Special Pathogens Branch, and Pichinde,
which was handled at BSL-2 at the Scripps Research
Institute.Molecular cloning of the glycoproteins of Amapari, Guanarito,
Junin, and Machupo
Total RNAwas extracted from supernatants of Vero-E6 cells
infected with the virus isolates Amapari, Guanarito, Junin, and
Machupo. TriPure reagent was added tissue culture medium
followed by chloroform extraction and matrix purification
(RNaid kit; Bio 101, La Jolla, CA). For reverse transcriptase
(RT) PCR amplification of the open reading frame (ORF) of
Amapri GP, we used the forward primer 5′CGCACAGTG-
GATCCTAGGCG3′ containing a novel BamHI site and the
reverse primer 5′GGAGCTCGAGCCTCTCTATTGGTG-
CCTTT3′, containing a novel XhoI site. The PCR product
was purified using the Qiagen (Valencia, CA) PCR purification
kit, cut with BamHI and XhoI, and inserted into pBluescript.
The sequence obtained was identical to the one reported by
Charrel et al. (2002) (Genbank # AF512834). For expression in
mammalian cell lines, the cDNA fragment encoding the ORF of
Amapari GP was inserted into the expression construct
pcAGGS. For this purpose, a 5′ fragment including the sequence
TACAGAACC upstream of the start ATG was amplified using
the forward primers 5′TACAGAACCATGGGTCAACTTGT-
TAGTTTCTTTCAG3′ and reverse primer 5′TGGAGTAAT-
CCCCAGCCACT3′, cut with XbaI and inserted into
pBluescript cut with SpeI (filled up with EcoPolI Klenow
fragment) and XbaI. A KpnI–XbaI fragment was cut out ligated
with a 3′ XbaI–XhoI fragment into pcAGGs cut with KpnI and
XbaI. The resultant expression construct pC-AMAGP was
verified by DNA sequencing.
For the RT-PCR amplification of the ORF of Guanarito GP,
the following primers were used: Guanarito: forward primer 5′
AATGAGCTCTACAGAACCATGGGACAGTTAATCAGT3′,
reverse primer: 5′AATCTCGAGTCAATGCTTTCTCTTCC-
A3′. The resulting PCR fragment was cut with SacI and XhoI,
inserted into pBluescript and sequenced by double strand DNA
sequencing. The sequence obtained for the ORF of Guanarito
GP was identical to the sequence of Guanarito GP isolate INH-
95551 reported by Charrel et al. (2002) (Genbank #
NC_005077). The Guanarito GP sequence was excised from a
verified clone by SacI and XhoI and inserted into pcAGGS,
resulting in the expression construct pC-GUAGP.
The GP ORF of Junin XJ13 was amplified using the forward
primer 5′AATGAGCTCTACAGAACCATGGGGCAGTT-
CATTAGC3′ and the reverse primer 5′AATCTCGAGTTAGT-
GTCCTCTACGCCA3′, cut with SacI and XhoI, inserted into
pBluescript and sequenced. The sequence obtained was
identical to the sequence of the Junin XJ13 GPC ORF
Genbank # NC_005081 except for the point mutations D155G
and L224P, which were found in three individual clones. The
cDNA of Junin XJ13 GP was cut out with SacI and XhoI and
inserted into pcAGGS, resulting in the expression construct
pC-JUNGP.
For the amplification of the GP ORF of Machupo, we used
the forward primer 5′AATGGTACCTACAGAACCATGGGG-
CAGCTTATCAGC3′ and the reverse primer 5′AATCTC-
GAGTTAATGTCTTTTGTGCCAGAT3′. The resulting PCR
fragment was cut with KpnI and XhoI, inserted into pBluescript
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identical to the sequence of Machupo GPC (Carvallo) Genbank
# NC_005078, reported by Charrel et al. (2002). The cDNA of
Machupo GP was cut out with KpnI and XhoI and inserted into
pcAGGS, resulting in the expression construct pC-MACGP.
Note that all expression constructs pC-AMAGP, pC-GUAGP,
pC-JUNGP, and pC-MACGP contain the same sequence
TACAGAACC immediately upstream of the start ATG,
minimizing differences in the efficiency of translation due to
sequences in the authentic 5′ untranslated region.
Production of retroviral pseudotypes
Recombinant Moloney murine leukemia virus (MLV) pseu-
dotyped was produced by transient transfection of the package
cell line GP2-293 (BD Biosciences) with the packable MLV
genome pLZRs-Luc-gfp, which contains a luciferase reporter
gene and a green fluorescent protein (GFP) reporter (Yang et al.,
1998), kindly provided by Dr. Gary Nabel. The GPs of
Amapari, Guanarito, Junin, Machupo, LFV, and VSV were
provided in trans by co-transfection with expression plasmids
containing their full-length cDNAs of LFVGP Josiah (Kunz et
al., 2005), Amapari, Guanarito, Junin, Machupo (see above),
and the VSVGP expression construct pVSV-G (BD Bios-
ciences), respectively. Briefly, 1.2 × 107 GP2–293 cells were
plated in poly-L-lysine coated T175 tissue culture flasks. After
16 h, cells were co-transfected with 20 μg each of pLZRs-Luc-
gfp and the GP expression plasmid using calcium phosphate.
Forty hours after transfection, cell supernatants were harvested
and cleared by centrifugation for 15 min at 3000 rpm. Retroviral
pseudotypes were then concentrated by ultracentrifugation at
25,000 rpm at 4 °C for 2 h using a SW28 rotor. Supernatants
were discarded after centrifugation and pellets resuspended for
16 h in DMEM, 20 mM HEPES, pH 7.5 at 4 °C as described
(Beyer et al., 2002). For determination of titers, monolayers of
HeLa cells were infected with serial dilutions of pseudotypes.
After 48 h, cells were fixed for 10 min in 2% (wt/vol) PFA, PBS.
GFP was detected using a rabbit anti-GFP polyclonal Ab
(Chemicon #3080) diluted 1:100 in PBS, 1% (v/v) FBS, 0.1%
(w/v) saponin incubated overnight at 4 °C. After several
washes, bound primary antibody was detected with a anti-rabbit
IgG-FITC (Fab)2 (1:50 in PBS/1% (v/v) FBS/0.1% (w/v)
saponin) applied for 45 min in the dark. Specimens were
examined under a fluorescence microscope and clusters of GFP
positive cells were counted and titers calculated.
Detection of arenavirus GP incorporated into retroviral
pseudotypes
For the detection of GP in the retroviral pseudotypes, three
independent preparations of concentrated viruses were analyzed
for each variant studied. Pseudotypes were produced, concen-
trated, and tittered as described above and diluted to 2 × 106 iu/
ml. Pseudotypes were coated in triplicate wells in 96-well EIA/
RIA high-bond microtiter plates (Corning) for 2 h at 6 °C and
non-specific binding blocked with 1% (wt/vol) BSA/PBS. For
the detection of GP, mAb 83.6 (anti-LCMVGP2) as applied at20 μg/ml for 2 h at 6 °C and detected with peroxidase-
conjugated anti-mouse IgG (1:1000) in a color reaction using
ABTS (2,2′-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)
substrate. OD (405) was measured with an ELISA reader. For
the determination of specific binding, background binding to
BSA was subtracted.
Binding of α-DG-Fc fusion proteins to arenaviruses
For binding of α-DG-Fc fusion protein, viruses (107 PFU/ml
in PBS) were immobilized in microtiter plates and incubated
with the α-DG-Fc fusion proteins. Bound α-DG-Fc was
detected with a combination of mouse anti-human IgG Fc
(1:500) and HRP-conjugated goat anti-mouse IgG (1:500).
Assays were developed with ABTS substrate and OD (405)
recorded in an ELISA reader. Background binding to BSAwas
subtracted.
Infection of cells with retroviral pseudotypes
Cells were plated in 96-well plates in a density of 104 cells/
well. After 24 h, retroviral pseudotypes were added at the
indicated MOI and incubated for 1 h at 37 °C. The viral particles
were removed, cells washed twice with DMEM, and fresh
medium added. For luciferase assay, the Steady-Glo luciferase
assay from Promega was used in all cell types except murine ES
cells. Due to the low transduction efficiency of MLV-based
vectors in ES cells, the 10 times more sensitive Bright-Glo
luciferase assay was used. Briefly, 48 h after infection, the 96
well plates were removed from the incubator and 100 μl
reagent/well luciferase assay reagent added. After 5 min to
allow complete lysis of cells, lysates were transferred into white
96 well-plates luminescence measured in a 96-well plate
luminometer (Bertold) using WinGlow software. Luminescence
was calculated as fold-increase over background signals
obtained from uninfected cells.
Blocking of pseudotype infection of cells with inactivated
viruses
For blocking, HEK293 cells cultured in 96 well plates
(2 × 103 cells/well) were incubated with the indicated
concentration of inactivated viruses in a total volume of
100 μl/well in 50% OPTIMEM/PBS for 2 h on ice. Then,
2 × 103 iu of retroviral pseudotypes was mixed with the same
concentrations of inactivated viruses in a total volume of 100 μl
OPTIMEM/PBS and the inoculum added to the cells for. After
45 min, supernatants were removed, and cells washed three
times with medium and incubated for 48 h. Infection was
quantified by luciferase assay as described above.
For blocking experiments with Pichinde, 2 × 103 HEK293
cells/well were cultured in Permanox 8-well LabTek tissue
chamber slides (NUNC). Cells were blocked with inactivated
viruses at the indicated ratios of inactivated infectious virus
particles (PFU) per cell for 2 h on ice applying a total volume of
100 μl. Cells were subsequently infected with 500 PFU of live
Pichinde virus in the presence of the blocking virus for 45 min.
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with medium. After 36 h of incubation, cells were fixed for
10 min in 2% (wt/vol) PFA in PBS. The GP of Pichinde virus
was detected using the broadly specific anti-GP mAbs 83.6 and
33.1 (undiluted hybridoma supernatants, 0.1% (wt/vol) sapo-
nin) incubated over night at 4 °C. After several washes, bound
primary antibody was detected with a anti-mouse IgG-FITC
(Fab)2 (1:50 in PBS/1% (v/v) FBS/0.1% (wt/vol) saponin)
applied for 45 min in the dark. Specimens were examined under
a fluorescence microscope and clusters of GP positive cells
were scored.
Enzyme treatment of HEK293H cells
HEK293H cells were grown in suspension cultures in
serum-free medium 293 SFMII as described above. For
enzyme treatment, 105 cells were transferred to 96-well plates
(triplicates) and washed twice in HBSS. Enzyme treatments of
cells in suspension were carried out as described (Kunz et al.,
2004). Proteases: Cells were resuspended in 100 μl HBSS, pH
7.5 containing 10 μg/ml proteinase K from T. album (Roche) or
10 μg/ml trypsin from bovine pancreas (Sigma). After
incubation for 1 h at 37 °C, 10% (vol/vol) FBS was added
to quench proteases. Phospholipases: Cells were resuspended
in 100 μl HBSS, pH 7.5 containing 10 U/ml Phospholipase A2
(PLA2) from Streptomyces violaceroruber (Sigma); 100 μl
HBSS, pH 7.3 containing 10 U/ml phospholipase C (PLC)
from Clostridium perfringens (Sigma); 100 μl HBSS, pH 7.0
containing 100 U/ml phospholipase D (PLD) from Streptomy-
ces species; and 100 μl HBSS, pH 7.5 containing 100 U/ml PI-
specific phospholipase C (PI-PLC) from B. cereus. The activity
of PI-PLC was verified by removal of the GPI-linked marker
protein from the surface of mouse EL-4 lymphoma cells as
described (Borrow and Oldstone, 1992). Endoglycosidases:
Cells were resuspended in 100 μl of 1% (wt/vol) BSA, HBSS,
pH 7.5 containing 1 mU/ml N-glycosidase A from sweet
almonds (PNGaseA, Roche). For treatment with neuraminidase
and O-glycosidase, 10 mU/ml O-glycosidase from Diplococcus
pneumoniae (Roche) was combined with 100 mU/ml neur-
aminidase from A. urefaciens (Calbiochem) in 1% (wt/vol)
BSA, HBSS, pH 7.5. Exoglycosidases: Cells were resuspended
in 100 μl of 1% (wt/vol) BSA, 50 mM HEPES, 5 mM CaCl2,
pH 7.0 containing 10 U/ml α-1–2,3 mannosidase from
Xanthomonas manihotis and α-1–6 mannosidase from Xantho-
monas sp. (New England Biolabs, NEB); 1% (wt/vol) BSA,
HBSS, pH 7.5 containing 10 U/ml α-N-acetyl-galactosaminase
from E. coli (NEB); 1% (wt/vol) BSA, HBSS, pH 7.5
containing 10 U/ml α-1–2 fucosidase from X. manihotis
(NEB); 1% (wt/vol) BSA, HBSS, pH 7.0 containing 100 mU/
ml neuraminidase from A. urefaciens; 1% (wt/vol) BSA,
HBSS, pH 7.0 containing 100 U/ml β-N acetyl-hexosamini-
dase from Streptomyces plicatus (NEB); and in 1% (wt/vol)
BSA, HBSS, pH 7.0 containing β(1–3,4,6) galactosidase
(Sigma). In control samples, cells were incubated with buffer
only. Enzyme treatment was for 1 h at 37 °C if not indicated
otherwise. Cells were then washed twice in 1% (vol/vol) FBS,
HBSS and cell viability checked by staining with 7-amino-actinomycin (7-AAD) (BD Biosciences). Briefly, 10 μl of cell
suspension was removed from each sample and 1 μl of 1:10
dilution of 7-AAD stock added to sample. After incubation for
10 min at room temperature, cells were washed twice in 1%
(vol/vol) FBS, HBSS and examined by fluorescence micros-
copy using a Zeiss Axiovert S100 microscope (Carl Zeiss Inc.
Thornwood, NY) fitted with a 20× objective, an AxioCam
digital camera, and an automated stage. Triplicates of 100 cells
in phase were counted and cells showing red fluorescence
scored as dead or dying. The percentage of viable cells was
calculated accordingly.
Cell viability after treatment with enzyme/without enzyme
(±) was as follows: PLA2: 91% (±6)/92 (±16); PLC: 79%
(±8)/88 (±11); PLD: 79% (±6)/89 (±13); PI-PLC: 81% (±9)/94
(±4); PNGaseA: 84% (±9)/95 (±4); neuraminidase/O-glyca-
nase 71% (±9)/93 (±5); α-1–2,3 mannosidase: 82% (±8)/94
(±10); α-N-acetyl-galactosaminase: 74% (±12)/92 (± 8); α-1–
2 fucosidase: 74% (±8)/91 (±6); neuraminidase alone: 64%
(±15)/71 (±8); β-N-acetyl-hexosaminidase: 69% (±13)/88
(±7); β-1–3,4,6 galactosidase 87% (±8)/94 (±7); proteinase
K: 82 (±9)/98 (±3); Trypsin: 91 (±5)/96 (±2).
For subsequent incubation with retroviral pseudotypes, 104
live cells were transferred to each well of a 96-well plates,
centrifuged for 5 min at 1200 rpm, and incubated with 104 iu of
retroviral pseudotypes in 293 SFMII, and incubated for 2 h on
ice. After two rapid wash-steps in 293 SFMII at 4 °C, cells were
resuspended 293 SFMII and incubated for 48 h. Infection was
assessed by luciferase assay.
Enzymatic remodeling of oligosaccharides on immobilized
glycoproteins
To verify the removal of protein-linked sugars by endo- and
exoglycosidases, we performed enzymatic remodeling of
oligosaccharides on immobilized glycoproteins as described
(Orberger et al., 1993). Briefly, purified control proteins
(transferrin, fetuin, asialofetuin, and carboxypeptidase Y) at a
concentration of 10 μg/ml in 100 mM carbonate/bicarbonate
buffer were immobilized in high-bond microtiter plates
(Corning). After washing five times with PBS, plates were
blocked with 1% (wt/vol) BSA in PBS for 1 h. After one wash
step in the corresponding reaction buffer, endo- and exoglyco-
sidases were added at the concentrations and buffer conditions
described above. After 1 h of incubation, enzymes were
removed by five wash steps with TBS, 0.1% (wt/vol) Tween-20
(TBST). Biotinylated lectins were applied at 10 μg/ml in lectin
binding buffer (3% (wt/vol) BSA, 50 mM Tris–HCl, 1 mM
CaCl2, 1 mMMgCl2, 1 mMMnCl2, 150 mM NaCl, pH 7.5) for
1 h at room temperature. After extensive washing, bound lectins
were detected with streptavidine-HRP (1:500) in lectin binding
buffer, followed by extensive washing in TBST and a color
reaction using ABTS substrate.
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